Inventor · disambiguated record
Charles Mcintyre
Also filed as: MCINTYRE CHARLES · MCINTYRE CHARLES A
5 granted patents·3 pending applications·22 citations·filing 2007–2022
78Inventor score
Top patents by PatentIndex Score
8 records- 0188US9962386B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted May 8, 2018·6 cites·39 claims
- 0287US9683003B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2015·Granted Jun 20, 2017·7 cites·55 claims
- 0386US10335410B2Heteroaryl compounds useful as inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2018·Granted Jul 2, 2019·4 cites·14 claims
- 0485US10780090B2Heteroaryl compounds useful as inhibitors of SUMO activating enzymeMILLENNIUM PHARM INC·Filed 2019·Granted Sep 22, 2020·1 cites·16 claims
- 0580US2023293522A1Heteroaryl compounds useful as inhibitors of sumo activating enzymeTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0677US9695154B2Heteroaryl inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2014·Granted Jul 4, 2017·4 cites·34 claims
- 0772US2022331316A1Heteroaryl compounds useful as inhibitors of sumo activating enzymeMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 0855US2010099695A1HCV NS3 Protease InhibitorsLIVERTON NIGEL J·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Mcintyre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →